323 related articles for article (PubMed ID: 10323594)
21. Aliphatic and heterocyclic analogues of arecaidine propargyl ester. Structure-activity relationships of mono- and bivalent ligands at muscarinic M1 (M4), M2 and M3 receptor subtypes.
Moser U; Gubitz C; Galvan M; Immel-Sehr A; Lambrecht G; Mutshcler E
Arzneimittelforschung; 1995 Apr; 45(4):449-55. PubMed ID: 7779140
[TBL] [Abstract][Full Text] [Related]
22. Expression of muscarinic receptor subtypes in salivary glands of rats, sheep and man.
Ryberg AT; Warfvinge G; Axelsson L; Soukup O; Götrick B; Tobin G
Arch Oral Biol; 2008 Jan; 53(1):66-74. PubMed ID: 17825245
[TBL] [Abstract][Full Text] [Related]
23. Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists.
Wang SZ; el-Fakahany EE
J Pharmacol Exp Ther; 1993 Jul; 266(1):237-43. PubMed ID: 7687290
[TBL] [Abstract][Full Text] [Related]
24. The interaction of the enantiomers of aceclidine with subtypes of the muscarinic receptor.
Ehlert FJ; Griffin MT; Glidden PF
J Pharmacol Exp Ther; 1996 Dec; 279(3):1335-44. PubMed ID: 8968358
[TBL] [Abstract][Full Text] [Related]
25. [Selective M1 muscarinic agonists: failure of therapeutic strategy against Alzheimer's disease or inappropriate tactics?].
Vamvakidès A
Ann Pharm Fr; 2003 May; 61(3):207-10. PubMed ID: 12714934
[TBL] [Abstract][Full Text] [Related]
26. Roles of threonine 192 and asparagine 382 in agonist and antagonist interactions with M1 muscarinic receptors.
Huang XP; Nagy PI; Williams FE; Peseckis SM; Messer WS
Br J Pharmacol; 1999 Feb; 126(3):735-45. PubMed ID: 10188986
[TBL] [Abstract][Full Text] [Related]
27. Mixed agonist-antagonist properties of clozapine at different human cloned muscarinic receptor subtypes expressed in Chinese hamster ovary cells.
Olianas MC; Maullu C; Onali P
Neuropsychopharmacology; 1999 Mar; 20(3):263-70. PubMed ID: 10063486
[TBL] [Abstract][Full Text] [Related]
28. M1 receptor agonist activity is not a requirement for muscarinic antinociception.
Sheardown MJ; Shannon HE; Swedberg MD; Suzdak PD; Bymaster FP; Olesen PH; Mitch CH; Ward JS; Sauerberg P
J Pharmacol Exp Ther; 1997 May; 281(2):868-75. PubMed ID: 9152396
[TBL] [Abstract][Full Text] [Related]
29. Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypes.
Dallanoce C; De Amici M; Barocelli E; Bertoni S; Roth BL; Ernsberger P; De Micheli C
Bioorg Med Chem; 2007 Dec; 15(24):7626-37. PubMed ID: 17889543
[TBL] [Abstract][Full Text] [Related]
30. On the unique binding and activating properties of xanomeline at the M1 muscarinic acetylcholine receptor.
Christopoulos A; Pierce TL; Sorman JL; El-Fakahany EE
Mol Pharmacol; 1998 Jun; 53(6):1120-30. PubMed ID: 9614217
[TBL] [Abstract][Full Text] [Related]
31. M2, M3 and M4, but not M1, muscarinic receptor subtypes are present in rat spinal cord.
Höglund AU; Baghdoyan HA
J Pharmacol Exp Ther; 1997 Apr; 281(1):470-7. PubMed ID: 9103533
[TBL] [Abstract][Full Text] [Related]
32. 1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M1 agonists: structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivatives.
Jeppesen L; Olesen PH; Hansen L; Sheardown MJ; Thomsen C; Rasmussen T; Jensen AF; Christensen MS; Rimvall K; Ward JS; Whitesitt C; Calligaro DO; Bymaster FP; Delapp NW; Felder CC; Shannon HE; Sauerberg P
J Med Chem; 1999 Jun; 42(11):1999-2006. PubMed ID: 10354408
[TBL] [Abstract][Full Text] [Related]
33. Ethanol disrupts carbamylcholine-stimulated release of arachidonic acid from Chinese hamster ovary cells expressing different subtypes of human muscarinic receptor.
Stair SM; May LG; Puhl HL; Phelps SH; Williams CL; Aronstam RS
Alcohol Clin Exp Res; 1998 Apr; 22(2):409-15. PubMed ID: 9581647
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo.
Ney P; Pandita RK; Newgreen DT; Breidenbach A; Stöhr T; Andersson KE
BJU Int; 2008 Apr; 101(8):1036-42. PubMed ID: 18279452
[TBL] [Abstract][Full Text] [Related]
35. Pseudo-noncompetitive antagonism of M1, M3, and M5 muscarinic receptor-mediated Ca2+ mobilization by muscarinic antagonists.
Kukkonen JP; Näsman J; Rinken A; Dementjev A; Akerman KE
Biochem Biophys Res Commun; 1998 Feb; 243(1):41-6. PubMed ID: 9473476
[TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of m1 selective muscarinic receptor antagonists1.
Augelli-Szafran CE; Blankley CJ; Jaen JC; Moreland DW; Nelson CB; Penvose-Yi JR; Schwarz RD; Thomas AJ
J Med Chem; 1999 Feb; 42(3):356-63. PubMed ID: 9986705
[TBL] [Abstract][Full Text] [Related]
37. M1, M3 and M5 muscarinic receptors stimulate mitogen-activated protein kinase.
Wotta DR; Wattenberg EV; Langason RB; el-Fakahany EE
Pharmacology; 1998 Apr; 56(4):175-86. PubMed ID: 9566019
[TBL] [Abstract][Full Text] [Related]
38. Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors.
Miller JH; Aagaard PJ; Gibson VA; McKinney M
J Pharmacol Exp Ther; 1992 Nov; 263(2):663-7. PubMed ID: 1331410
[TBL] [Abstract][Full Text] [Related]
39. Muscarinic acetylcholine receptor (mAChR) inhibitor from snake venom: interaction with subtypes of human mAChR.
Miyoshi S; Tu AT
Arch Biochem Biophys; 1999 Sep; 369(1):114-8. PubMed ID: 10462446
[TBL] [Abstract][Full Text] [Related]
40. Muscarinic cholinoceptor activation modulates DNA synthesis and CD40 expression in fibroblast cells.
Casanova M; Furlán C; Sterin-Borda L; Borda ES
Auton Autacoid Pharmacol; 2006 Jul; 26(3):293-301. PubMed ID: 16879495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
